J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rudling, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rudling, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol 33, 493-501, Copyright © 1992 by Lipid Research, Inc.


ARTICLES

Hepatic mRNA levels for the LDL receptor and HMG-CoA reductase show coordinate regulation in vivo

M Rudling
Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas 75235.

A sensitive solution hybridization assay using autologous cRNA probes was developed with the aim to study the simultaneous regulation of hepatic mRNA levels, on a quantitative basis, for the LDL receptor (LDLr), HMG-CoA reductase, and cholesterol 7 alpha-hydroxylase (Cho-7- hx) in C57BL/6J mice. With the purpose to suppress and stimulate transcript levels respectively, animals received established high fat diets, cholesterol-enriched diets, and a diet supplemented with mevinolin and colestipol. One hundred nineteen animals were investigated in six separate experiments. In spite of an eightfold increase in hepatic cholesterol induced by a high fat diet, the LDLr and the HMG-CoA reductase mRNA levels were only reduced to 60-70% and 25-50% of control values, respectively. When the data from all animals were analyzed, a strong positive correlation was obtained between the mRNA levels for the LDLr and HMG-CoA reductase (r = 0.79, P less than 0.001). A significant relation remained when control animals only were analyzed (n = 42, r = 0.59, P less than 0.001). Cho-7-hx mRNA showed a regulatory pattern that differed from that of the LDLr and HMG-CoA reductase; feeding cholesterol at 1.7% and 5% but not at 0.4% elevated the mRNA levels for Cho-7-hx while the LDLr and HMG-CoA reductase mRNA levels were maximally suppressed already at 0.4% of dietary cholesterol. The results show that the mRNA levels for the LDLr and HMG- CoA reductase are regulated in parallel in the liver in vivo during various metabolic perturbations as well as at normal physiologic conditions.(ABSTRACT TRUNCATED AT 250 WORDS)
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Nutr.Home page
M. Torres-Gonzalez, S. Shrestha, M. Sharman, H. C. Freake, J. S. Volek, and M. L. Fernandez
Carbohydrate Restriction Alters Hepatic Cholesterol Metabolism in Guinea Pigs Fed a Hypercholesterolemic Diet
J. Nutr., October 1, 2007; 137(10): 2219 - 2223.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
C.-W. Chen and H.-H. Cheng
A Rice Bran Oil Diet Increases LDL-Receptor and HMG-CoA Reductase mRNA Expressions and Insulin Sensitivity in Rats with Streptozotocin/Nicotinamide-Induced Type 2 Diabetes
J. Nutr., June 1, 2006; 136(6): 1472 - 1476.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M. Patalay, I. E. Lofgren, H. C. Freake, S. I. Koo, and M. L. Fernandez
The Lowering of Plasma Lipids following a Weight Reduction Program Is Related to Increased Expression of the LDL Receptor and Lipoprotein Lipase
J. Nutr., April 1, 2005; 135(4): 735 - 739.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y. Suarez, C. Fernandez, D. Gomez-Coronado, A. J. Ferruelo, A. Davalos, J. Martinez-Botas, and M. A. Lasuncion
Synergistic upregulation of low-density lipoprotein receptor activity by tamoxifen and lovastatin
Cardiovasc Res, November 1, 2004; 64(2): 346 - 355.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
K. N. Maxwell, R. E. Soccio, E. M. Duncan, E. Sehayek, and J. L. Breslow
Novel putative SREBP and LXR target genes identified by microarray analysis in liver of cholesterol-fed mice
J. Lipid Res., November 1, 2003; 44(11): 2109 - 2119.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
S. Pal, N. Ho, C. Santos, P. Dubois, J. Mamo, K. Croft, and E. Allister
Red Wine Polyphenolics Increase LDL Receptor Expression and Activity and Suppress the Secretion of ApoB100 from Human HepG2 Cells
J. Nutr., March 1, 2003; 133(3): 700 - 706.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Rudling, B. Angelin, L. Stahle, E. Reihner, S. Sahlin, H. Olivecrona, I. Bjorkhem, and C. Einarsson
Regulation of Hepatic Low-Density Lipoprotein Receptor, 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase, and Cholesterol 7{alpha}-Hydroxylase mRNAs in Human Liver
J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4307 - 4313.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Bjorkhem, Z. Araya, M. Rudling, B. Angelin, C. Einarsson, and K. Wikvall
Differences in the Regulation of the Classical and the Alternative Pathway for Bile Acid Synthesis in Human Liver. NO COORDINATE REGULATION OF CYP7A1 AND CYP27A1
J. Biol. Chem., July 19, 2002; 277(30): 26804 - 26807.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Galman, B. Angelin, and M. Rudling
Prolonged Stimulation of the Adrenals by Corticotropin Suppresses Hepatic Low-Density Lipoprotein and High-Density Lipoprotein Receptors and Increases Plasma Cholesterol
Endocrinology, May 1, 2002; 143(5): 1809 - 1816.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
M. RUDLING and B. ANGELIN
Growth hormone reduces plasma cholesterol in LDL receptor-deficient mice
FASEB J, June 1, 2001; 15(8): 1350 - 1356.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
H. Jurevics, J. Hostettler, C. Barrett, P. Morell, and A. D. Toews
Diurnal and dietary-induced changes in cholesterol synthesis correlate with levels of mRNA for HMG-CoA reductase
J. Lipid Res., July 1, 2000; 41(7): 1048 - 1054.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. Parini, B. Angelin, A. Stavreus-Evers, B. Freyschuss, H. Eriksson, and M. Rudling
Biphasic Effects of the Natural Estrogen 17{beta}-Estradiol on Hepatic Cholesterol Metabolism in Intact Female Rats
Arterioscler. Thromb. Vasc. Biol., July 1, 2000; 20(7): 1817 - 1823.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Yu, F. Wang, M. Kan, C. Jin, R. B. Jones, M. Weinstein, C.-X. Deng, and W. L. McKeehan
Elevated Cholesterol Metabolism and Bile Acid Synthesis in Mice Lacking Membrane Tyrosine Kinase Receptor FGFR4
J. Biol. Chem., May 12, 2000; 275(20): 15482 - 15489.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
G. C. Ness and C. M. Chambers
Feedback and Hormonal Regulation of Hepatic 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase: The Concept of Cholesterol Buffering Capacity
Experimental Biology and Medicine, May 1, 2000; 224(1): 8 - 19.
[Abstract] [Full Text]


Home page
Physiol. Rev.Home page
G. J. Schroepfer Jr.
Oxysterols: Modulators of Cholesterol Metabolism and Other Processes
Physiol Rev, January 1, 2000; 80(1): 361 - 554.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
F. Lammert, D. Q-H. Wang, B. Paigen, and M. C. Carey
Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: integrated activities of hepatic lipid regulatory enzymes
J. Lipid Res., November 1, 1999; 40(11): 2080 - 2090.
[Abstract] [Full Text]


Home page
J. Lipid Res.Home page
L. Nilsson, M. Gåfvels, L. Musakka, K. Ensler, D. K. Strickland, B. Angelin, A. Hamsten, and P. Eriksson
VLDL activation of plasminogen activator inhibitor-1 (PAI-1) expression: involvement of the VLDL receptor
J. Lipid Res., May 1, 1999; 40(5): 913 - 919.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. Parini, B. Angelin, and M. Rudling
Cholesterol and Lipoprotein Metabolism in Aging : Reversal of Hypercholesterolemia by Growth Hormone Treatment in Old Rats
Arterioscler. Thromb. Vasc. Biol., April 1, 1999; 19(4): 832 - 839.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Schwarz, E. G. Lund, R. Lathe, I. Bjorkhem, and D. W. Russell
Identification and Characterization of a Mouse Oxysterol 7alpha -Hydroxylase cDNA
J. Biol. Chem., September 19, 1997; 272(38): 23995 - 24001.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. Parini, B. Angelin, and M. Rudling
Importance of Estrogen Receptors in Hepatic LDL Receptor Regulation
Arterioscler. Thromb. Vasc. Biol., September 1, 1997; 17(9): 1800 - 1805.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
W. Liao, B. Angelin, and M. Rudling
Lipoprotein Metabolism in the Fat Zucker Rat: Reduced Basal Expression but Normal Regulation of Hepatic Low Density Lipoprotein Receptors
Endocrinology, August 1, 1997; 138(8): 3276 - 3282.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
W. Liao, M. Rudling, and B. Angelin
Novel Effects of Histamine on Lipoprotein Metabolism: Suppression of Hepatic Low Density Lipoprotein Receptor Expression and Reduction of Plasma High Density Lipoprotein Cholesterol in the Rat
Endocrinology, May 1, 1997; 138(5): 1863 - 1870.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. C. Henson, S. J. Greene, B. C. Reggio, W. Shi, and K. F. Swan
Effects of Reduced Maternal Lipoprotein-Cholesterol Availability on Placental Progesterone Biosynthesis in the Baboon
Endocrinology, April 1, 1997; 138(4): 1385 - 1391.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
W. Liao, M. Rudling, and B. Angelin
Contrasting Effects of Growth Hormone and Insulin-Like Growth Factor I on the Biological Activities of Endotoxin in the Rat
Endocrinology, January 1, 1997; 138(1): 289 - 295.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Basheeruddin, X. Li, C. Rechtoris, and T. Mazzone
Platelet-Derived Growth Factor Enhances Sp1 Binding to the LDL Receptor Gene
Arterioscler. Thromb. Vasc. Biol., August 1, 1995; 15(8): 1248 - 1254.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. M. Stulnig, H. Klocker, H. J. Harwood Jr, G. Jurgens, D. Schonitzer, E. Jarosch, L. A. Huber, A. Amberger, and G. Wick
In Vivo LDL Receptor and HMG-CoA Reductase Regulation in Human Lymphocytes and Its Alterations During Aging
Arterioscler. Thromb. Vasc. Biol., July 1, 1995; 15(7): 872 - 878.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
S. C. Rumsey, N. F. Galeano, B. Lipschitz, and R. J. Deckelbaum
Oleate and Other Long Chain Fatty Acids Stimulate Low Density Lipoprotein Receptor Activity by Enhancing Acyl Coenzyme A:Cholesterol Acyltransferase Activity and Altering Intracellular Regulatory Cholesterol Pools in Cultured Cells
J. Biol. Chem., April 28, 1995; 270(17): 10008 - 10016.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Sakthivel, J.-C. Zhang, D. K. Strickland, M. Gafvels, and K. R. McCrae
Regulation of the Ligand Binding Activity of the Human Very Low Density Lipoprotein Receptor by Protein Kinase C-dependent Phosphorylation
J. Biol. Chem., January 5, 2001; 276(1): 555 - 562.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 1992 by the American Society for Biochemistry and Molecular Biology.